Novartis takes on Sanofi, Amgen with $9.7bn takeover of heart drug maker
Swiss drugmaker betting on cholesterol-lowering prospect
Swiss drugmaker betting on cholesterol-lowering prospect
Eyecare business had been problematic since Novartis bought it for $52 billion in 2011
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices